Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-P16-093 PET/CT in Primary Sjögren's Syndrome
NCT06049368Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of 68Ga-P16-093 in primary Sjögren's syndrome, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
68Ga-P16-093
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on NCT06049368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06049368.